Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313175922> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4313175922 endingPage "312" @default.
- W4313175922 startingPage "309" @default.
- W4313175922 abstract "Background: Immune Thrombocytopenia Purpura (ITP) is an autoimmune disease characterized by a low level of platelets in the blood caused by accelerated platelet destruction or disruption of the thrombopoiesis due to antibodies to platelets. Drugs with similar functions to thrombopoietins (TPO) such as eltrombopag and romiplostim have been widely used and have been shown to be quite successful in treating ITP in nonpregnant patients. This case study aims to evaluate eltrombopag therapy's role in managing the refractory ITP in pregnant women.Case Presentation: A 25-year-old patient, a housewife, presented to the obstetrics clinic at Sanjiwani Hospital for the first time at a gestational age of 13 weeks for her third pregnancy, with a history of two abortions. ITP was diagnosed in 2017 during the second abortion treatment. The platelet examination results were between 32,000-66,000/?l, with platelet count during delivery planning at 34 weeks of 41,000/?l. The patient was diagnosed with chronic refractory ITP and was considered for second-line drug administration. Intravenous Immunoglobulin Therapy (IVIG) and anti-D administration as second-line drugs were not possible due to cost. The patient was given 50 mg eltrombopag per day for a week. The platelet counts increased to 202,000/?l a week after therapy. The patient then underwent vaginal delivery with a baby weight of 2,850 gram, Apgar Score of 8-10. The baby was exclusively breastfed and subjected to clinical monitoring and laboratory tests. The patient's clinical condition was favorable and the platelets fell to 20,000/?l nineteen days after delivery.Conclusion: In this case, the patient with chronic ITP refractory to steroid therapy showed an immediate response to eltrombopag. However, the platelet level decreased two weeks after the treatment cessation. More studies are needed on the use of eltrombopag in pregnant women." @default.
- W4313175922 created "2023-01-06" @default.
- W4313175922 creator A5006664960 @default.
- W4313175922 creator A5069443016 @default.
- W4313175922 date "2021-04-30" @default.
- W4313175922 modified "2023-10-14" @default.
- W4313175922 title "Management of pregnant women with Refractory Immune Thrombocytopenia Purpura (ITP) receiving eltrombopag therapy at Sanjiwani Hospital, Gianyar, Indonesia" @default.
- W4313175922 doi "https://doi.org/10.15562/ism.v12i1.958" @default.
- W4313175922 hasPublicationYear "2021" @default.
- W4313175922 type Work @default.
- W4313175922 citedByCount "0" @default.
- W4313175922 crossrefType "journal-article" @default.
- W4313175922 hasAuthorship W4313175922A5006664960 @default.
- W4313175922 hasAuthorship W4313175922A5069443016 @default.
- W4313175922 hasBestOaLocation W43131759221 @default.
- W4313175922 hasConcept C109159458 @default.
- W4313175922 hasConcept C121332964 @default.
- W4313175922 hasConcept C126322002 @default.
- W4313175922 hasConcept C131872663 @default.
- W4313175922 hasConcept C141071460 @default.
- W4313175922 hasConcept C142424586 @default.
- W4313175922 hasConcept C187212893 @default.
- W4313175922 hasConcept C2776915898 @default.
- W4313175922 hasConcept C2776958478 @default.
- W4313175922 hasConcept C2777863708 @default.
- W4313175922 hasConcept C2779234561 @default.
- W4313175922 hasConcept C2779705218 @default.
- W4313175922 hasConcept C2779771385 @default.
- W4313175922 hasConcept C2780588981 @default.
- W4313175922 hasConcept C28328180 @default.
- W4313175922 hasConcept C2993327898 @default.
- W4313175922 hasConcept C54355233 @default.
- W4313175922 hasConcept C71924100 @default.
- W4313175922 hasConcept C86803240 @default.
- W4313175922 hasConcept C87355193 @default.
- W4313175922 hasConcept C89560881 @default.
- W4313175922 hasConceptScore W4313175922C109159458 @default.
- W4313175922 hasConceptScore W4313175922C121332964 @default.
- W4313175922 hasConceptScore W4313175922C126322002 @default.
- W4313175922 hasConceptScore W4313175922C131872663 @default.
- W4313175922 hasConceptScore W4313175922C141071460 @default.
- W4313175922 hasConceptScore W4313175922C142424586 @default.
- W4313175922 hasConceptScore W4313175922C187212893 @default.
- W4313175922 hasConceptScore W4313175922C2776915898 @default.
- W4313175922 hasConceptScore W4313175922C2776958478 @default.
- W4313175922 hasConceptScore W4313175922C2777863708 @default.
- W4313175922 hasConceptScore W4313175922C2779234561 @default.
- W4313175922 hasConceptScore W4313175922C2779705218 @default.
- W4313175922 hasConceptScore W4313175922C2779771385 @default.
- W4313175922 hasConceptScore W4313175922C2780588981 @default.
- W4313175922 hasConceptScore W4313175922C28328180 @default.
- W4313175922 hasConceptScore W4313175922C2993327898 @default.
- W4313175922 hasConceptScore W4313175922C54355233 @default.
- W4313175922 hasConceptScore W4313175922C71924100 @default.
- W4313175922 hasConceptScore W4313175922C86803240 @default.
- W4313175922 hasConceptScore W4313175922C87355193 @default.
- W4313175922 hasConceptScore W4313175922C89560881 @default.
- W4313175922 hasIssue "1" @default.
- W4313175922 hasLocation W43131759221 @default.
- W4313175922 hasOpenAccess W4313175922 @default.
- W4313175922 hasPrimaryLocation W43131759221 @default.
- W4313175922 hasRelatedWork W1968652207 @default.
- W4313175922 hasRelatedWork W1974170726 @default.
- W4313175922 hasRelatedWork W2035714642 @default.
- W4313175922 hasRelatedWork W2148395100 @default.
- W4313175922 hasRelatedWork W2511530597 @default.
- W4313175922 hasRelatedWork W2557816942 @default.
- W4313175922 hasRelatedWork W2592516945 @default.
- W4313175922 hasRelatedWork W4210963919 @default.
- W4313175922 hasRelatedWork W4248671633 @default.
- W4313175922 hasRelatedWork W4256075833 @default.
- W4313175922 hasVolume "12" @default.
- W4313175922 isParatext "false" @default.
- W4313175922 isRetracted "false" @default.
- W4313175922 workType "article" @default.